EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Anticancer Activity of Novel Sulfanyl-Substituted Hydrazone Compounds in Hepatocellular Carcinoma: In Vitro, In Silico, and In Ovo Studies

Hatice Başpinar Küçük iD, Tülay Yildiz iD, Yaren Arasan, Buse Meriç Açar iD, Duygu Kurtoğlu, Aslı Kutlu, Remzi Okan Akar iD, Sinem Kiliç, Demet Gül Eryilmaz, Engin Ulukaya iD

ACS Omega · 17.03.2026 · 11 (10) · 16657-16672

DOI: 10.1021/acsomega.5c13125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 05.03.2026. Verfasst von Hatice Başpinar Küçük und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Engineering, Department of Chemistry, Organic Chemistry Division, Istanbul University-Cerrahpasa, Istanbul 34320, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul ??niversitesi-Cerrahpasa.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Faculty of Engineering, Department of Chemistry, Organic Chemistry Division, Istanbul University-Cerrahpasa, Istanbul 34320, Turkey.
  • Molecular Cancer Research Center (ISUMKAM), Istinye University, Istanbul 34396, Turkey.
  • Institute of Graduate Education, Molecular Oncology Program, Istinye University, Istanbul 34396, Turkey.
  • Faculty of Engineering and Natural Science, Department of Molecular Biology and Genetics, Istinye University, Istanbul 34396, Turkey.
  • Faculty of Medical School, Department of Clinical Biochemistry, Istinye University, Istanbul 34396, Turkey.

ORCID-Profile: Hatice Başpinar Küçük, Tülay Yildiz, Buse Meriç Açar, Remzi Okan Akar, Engin Ulukaya

Förderung

  • Istanbul ??niversitesi-Cerrahpasa

Zitieren

APA

Başpinar Küçük, H., Yildiz, T., Arasan, Y., Açar, B. M., Kurtoğlu, D., Kutlu, A., Akar, R. O., Kiliç, S., Eryilmaz, D. G., & Ulukaya, E. (2026). Evaluation of Anticancer Activity of Novel Sulfanyl-Substituted Hydrazone Compounds in Hepatocellular Carcinoma: In Vitro, In Silico, and In Ovo Studies. ACS Omega, 11(10), 16657-16672. https://doi.org/10.1021/acsomega.5c13125

Vancouver

Başpinar Küçük H, Yildiz T, Arasan Y, Açar BM, Kurtoğlu D, Kutlu A, et al. Evaluation of Anticancer Activity of Novel Sulfanyl-Substituted Hydrazone Compounds in Hepatocellular Carcinoma: In Vitro, In Silico, and In Ovo Studies. ACS Omega. 2026;11(10):16657-16672. doi:10.1021/acsomega.5c13125

BibTeX
@article{BapinarKk2026,
  author = {Başpinar Küçük, Hatice and Yildiz, Tülay and Arasan, Yaren and Açar, Buse Meriç and Kurtoğlu, Duygu and Kutlu, Aslı and Akar, Remzi Okan and Kiliç, Sinem and Eryilmaz, Demet Gül and Ulukaya, Engin},
  title = {Evaluation of Anticancer Activity of Novel Sulfanyl-Substituted Hydrazone Compounds in Hepatocellular Carcinoma: In Vitro, In Silico, and In Ovo Studies},
  journal = {ACS Omega},
  year = {2026},
  volume = {11},
  number = {10},
  pages = {16657--16672},
  doi = {10.1021/acsomega.5c13125}
}
Kostenlos starten →